Sequent Scientific Ltd. News

NSE: Sequent Scientific Industry : Pharmaceuticals & Drugs

Sequent Scientific consolidates residual stake in Evance Group

This consolidation of Evance Group further builds on Aliviraas strong track record of successfully acquiring and integrating into its global businesses

12 Jan 2022, 14:23 PM

bookmark

Sequent Scientificas arm inks pact to acquire 100% stake in Nourrie

The acquisition will be made through Evance, subsidiary of Alivira Brazil, for a cash consideration of BRL 27 Million

16 Dec 2021, 15:46 PM

bookmark

SeQuent Scientific gets EUGMP approval for tablets dosage manufacturing line in Turkey

The company has already embarked upon significant expansion in Turkey to meet the growing requirements of the local market

15 Jul 2021, 09:23 AM

bookmark

SeQuent Scientific launches Citramox LA in EU

This new approval for SeQuent builds on the recent approvals of Tulazzin (Tulathromycin) and Halofusol (Halofuginone) in Europe

10 Dec 2020, 14:48 PM

bookmark

Sequent Scientific launches Halofusol Oral Solution in European countries

The company is also planning to extend the launch to other geographies

01 Dec 2020, 11:38 AM

bookmark

Sequent Scientific completes acquisition of 40% stake in Provet

On completion of the said transaction, Provet has become a Wholly Owned Subsidiary of the Company

03 Nov 2020, 10:45 AM

bookmark

India Ratings and Research upgrades Sequent Scientific's credit ratings with positive outlook

The Credit rating agency has upgraded the Sequent Scientific's Long-Term Issuer Rating to 'A' from 'A-'

12 Oct 2020, 12:51 PM

bookmark

Sequent Scientific completes acquisition of 15% stake in Fendigo BV

On completion of the said transaction, Fendigo BV has become a Wholly Owned Subsidiary of the Company

09 Oct 2020, 16:51 PM

bookmark

Sequent Scientific completes sale of investments held in Strides Pharma

The proceeds of the sale will be predominantly utilised to consolidate the company's shareholding in Provet

26 Sep 2020, 09:55 AM

bookmark

Sequent Scientific gets shareholders' nod to acquire 40% stake in Provet

The said transaction is expected to be completed on or before October 31, 2020

23 Sep 2020, 09:43 AM

bookmark

Carlyle Group enters into binding agreements to acquire majority stake in SeQuent Scientific

Following the completion of this transaction, CA Harbor Investments will become the new promoter of SeQuent

09 May 2020, 11:50 AM

bookmark

Sequent Scientific gets WHO - GENEVA's approval for API Praziquantel

This approval further emphasizes focus on compliance standards

12 Mar 2020, 16:21 PM

bookmark

Sequent Scientific inaugurates new state-of-art animal health R&D centre at Mumbai

This unique centre with strong injectable focus has capabilities to develop products of 8 different dosage forms

03 Feb 2020, 15:49 PM

bookmark

Today's price summary

Stock DNA

1 Years Returns

STOCK

-106.44

SECTOR

-90.39

SENSEX

-76.53

Industry

Pharma

MARKET CAP

Rs 4,769 Cr

PE (TTM)

64.64

DIVIDEND YIELD

0.26%

Moving average Buy Sell
Technical Indicator Buy Sell
Moving average Buy Sell
Technical Indicator Buy Sell
Moving average Buy Sell
Technical Indicator Buy Sell